We are live on ! Find out more
ELDN icon

Eledon Pharmaceuticals
ELDN

48 hedge funds and large institutions have $70M invested in Eledon Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 9

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

9% more funds holding

Funds holding: 44 → 48 (+4)

23% less capital invested

Capital invested by funds: $91.2M → $70M (-$21.3M)

Holders
48
Holders Change
+4
Holders Change %
+9.09%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
18
Reduced
9
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KCM
Kingdon Capital Management
New York
+$1.5M
2
AC
Ascend Capital
California
+$1.36M
3
SCM
Sio Capital Management
New York
+$1.12M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$452K
5
GOCM
Green Owl Capital Management
New York
+$327K

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$3.17M
2
AIC
AWM Investment Company
New York
-$1.47M
3
Deutsche Bank
Deutsche Bank
Germany
-$664K
4
PA
Perceptive Advisors
New York
-$368K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$351K
Name Holding Trade Value Shares
Change 		Change in
Stake
William Blair & Company
26
William Blair & Company
Illinois
$206K -$269K -122 -52%
BIM
27
BlackRock Investment Management
Delaware
$201K +$26.5K +12 +12%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$190K +$24.3K +11 +12%
Goldman Sachs
29
Goldman Sachs
New York
$169K -$287K -130 -59%
ARTA
30
A.R.T. Advisors
New York
$156K +$188K +85 New
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$124K – – –
TA
32
Teachers Advisors
New York
$68K – – –
Citigroup
33
Citigroup
New York
$67K +$66.2K +30 +500%
NFA
34
Nationwide Fund Advisors
Ohio
$50K +$4.41K +2 +8%
Morgan Stanley
35
Morgan Stanley
New York
$44K +$48.5K +22 +1,100%
AIG
36
American International Group
New York
$42K – – –
Creative Planning
37
Creative Planning
Kansas
$37K – – –
BA
38
BlackRock Advisors
Delaware
$32K +$11K +5 +42%
TRCT
39
Tower Research Capital (TRC)
New York
$27K +$33.1K +15 New
SO
40
STRS Ohio
Ohio
$21K – – –
AllianceBernstein
41
AllianceBernstein
Tennessee
$16K +$19.9K +9 New
SFPIA
42
Stevens First Principles Investment Advisors
California
$12K – – –
Wells Fargo
43
Wells Fargo
California
$11K +$13.2K +6 New
UBS Group
44
UBS Group
Switzerland
$2K -$13.2K -6 -86%
Barclays
45
Barclays
United Kingdom
$2K -$4.41K -2 -67%
MAA
46
Managed Account Advisors
New Jersey
$2K – – –
BlackRock
47
BlackRock
New York
$2K +$2.21K +1 New
BNP Paribas Financial Markets
48
BNP Paribas Financial Markets
France
$1.62K +$2.21K +1 New
Bank of America
49
Bank of America
North Carolina
$1K – – –
RG
50
Redmile Group
California
– -$3.17M -1,328 Closed
1
2
3

ELDN Hedge Fund Activity: Q1 2015 in Review

48 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Eledon Pharmaceuticals (ELDN) for Q1 2015, worth a combined $70M — down 23% from $91.2M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ELDN positions and 5 closed out — a net gain of 4 holders — while 18 added to existing stakes and 9 trimmed.

The largest buyer was Kingdon Capital Management, adding an estimated $1.5M. The largest seller was Redmile Group, exiting entirely with an estimated $3.17M sold.

  • 48 institutional investors held Eledon Pharmaceuticals (ELDN) as of Q1 2015, up from 44 in Q4 2014.
  • Funds reported $70M of Eledon Pharmaceuticals stock for Q1 2015, down 23% quarter-over-quarter.
  • 9 funds opened new Eledon Pharmaceuticals positions in Q1 2015 and 5 closed out, a net change of +4 holders.
  • The largest Eledon Pharmaceuticals buyer in Q1 2015 was Kingdon Capital Management, an estimated $1.5M added.
  • The largest Eledon Pharmaceuticals seller in Q1 2015 was Redmile Group, an estimated $3.17M sold.

Based on aggregated 13F filings for Q1 2015.